The Life Science business of Merck KGaA, Darmstadt, Germany Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
HUB Organoids official news RSS · 行业原文收录 · 来源发布：Mon Jan 06 2025 13:23:34 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Reinforces company’s commitment to differentiated solutions that enable faster and more effective drug development HUB’s organoid offering complements company’s cell culture portfolio of media, reagents, and benchtop instrumentation Organoids provide drug response data earlier in the development process while helping to maintain project scale Darmstadt, Germany, January 6, 2025 – The Life Science
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。